We are live on ! Find out more
MRKR icon

Marker Therapeutics
MRKR

74 hedge funds and large institutions have $75.8M invested in Marker Therapeutics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 17 increasing their positions, 25 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

471% more call options, than puts

Call options by funds: $2.53M | Put options by funds: $443K

33% more capital invested

Capital invested by funds: $56.8M → $75.8M (+$19M)

0.07% more ownership

Funds ownership: 3.2% → 3.27% (+0.07%)

0% more funds holding

Funds holding: 74 → 74 (0)

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

32% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 25

Holders
74
Holders Change
–
Holders Change %
0%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
17
Reduced
25
Closed
16
Calls
$2.53M
Puts
$443K
Net Calls
+$2.09M
Net Calls Change
+$1.47M

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$3.19M
2
Millennium Management
Millennium Management
New York
+$3.01M
3
Two Sigma Investments
Two Sigma Investments
New York
+$2.35M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.59M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.05M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.79M
2
KCM
Kennedy Capital Management
Missouri
-$3.18M
3
State Street
State Street
Massachusetts
-$1.01M
4
Northern Trust
Northern Trust
Illinois
-$580K
5
N
Nuveen
North Carolina
-$431K
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
26
Parametric Portfolio Associates
Washington
$209K -$41.1K -1,561 -17%
WS
27
Wedbush Securities
California
$195K – – –
Dimensional Fund Advisors
28
Dimensional Fund Advisors
Texas
$191K +$33.5K +1,273 +23%
Osaic Holdings
29
Osaic Holdings
Arizona
$144K +$84.1K +3,195 +163%
Morgan Stanley
30
Morgan Stanley
New York
$143K +$94.4K +3,587 +234%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$133K +$11K +419 +10%
CSS
32
Cubist Systematic Strategies
Connecticut
$132K -$64.9K -2,464 -34%
HF
33
HRT Financial
New York
$127K +$120K +4,557 New
ECM
34
ExodusPoint Capital Management
New York
$122K +$86.8K +3,298 +306%
SFI
35
Susquehanna Fundamental Investments
Pennsylvania
$120K +$114K +4,315 New
AQR Capital Management
36
AQR Capital Management
Connecticut
$116K +$109K +4,152 New
NRS
37
Neville Rodie & Shaw
New York
$84K – – –
RAM
38
Riggs Asset Management
Pennsylvania
$82K -$10.5K -400 -12%
BCI
39
Brinker Capital Investments
Pennsylvania
$82K +$2.24K +85 +3%
Charles Schwab
40
Charles Schwab
California
$75K -$124K -4,715 -64%
PCA
41
Personal Capital Advisors
California
$72K – – –
JIP
42
Jaffetilchin Investment Partners
Florida
$71K -$11.8K -450 -15%
Jane Street
43
Jane Street
New York
$70K +$1.11K +42 +2%
WA
44
WealthTrust Axiom
Pennsylvania
$68K +$5.27K +200 +9%
XT
45
XTX Topco
Cayman Islands
$67K +$63.6K +2,417 New
Bank of America
46
Bank of America
North Carolina
$58K -$99.1K -3,765 -65%
HSBC Holdings
47
HSBC Holdings
United Kingdom
$54K +$53 +2 +0.1%
Commonwealth Equity Services
48
Commonwealth Equity Services
Massachusetts
$49K +$46.9K +1,783 New
HighTower Advisors
49
HighTower Advisors
Illinois
$47K – – –
Bank of New York Mellon
50
Bank of New York Mellon
New York
$44K -$164K -6,218 -80%
1
2
3 4

MRKR Hedge Fund Activity: Q2 2021 in Review

74 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q2 2021, worth a combined $75.8M — up 33% from $56.8M a quarter earlier.

Fund positioning in MRKR was balanced in Q2 2021: 16 funds opened new positions, 16 closed out, 17 added to existing stakes and 25 trimmed.

The largest buyer was Two Sigma Advisers, adding an estimated $3.19M. The largest seller was BlackRock, cutting an estimated $4.79M.

  • 74 institutional investors held Marker Therapeutics (MRKR) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $75.8M of Marker Therapeutics stock for Q2 2021, up 33% quarter-over-quarter.
  • 16 funds opened new Marker Therapeutics positions in Q2 2021 and 16 closed out, a net change of 0 holders.
  • The largest Marker Therapeutics buyer in Q2 2021 was Two Sigma Advisers, an estimated $3.19M added.
  • The largest Marker Therapeutics seller in Q2 2021 was BlackRock, an estimated $4.79M sold.

Based on aggregated 13F filings for Q2 2021.